THEON INTERNATIONAL Acquires 9.77% Stake in Exosens from HLD Europe

January 7, 2026

HLD Europe has completed the sale of a 9.77% stake in Exosens to THEON INTERNATIONAL at a price of €54 per share. After the transaction HLD Europe retains a 22.35% stake in Exosens; THEON (a European night-vision and thermal imaging manufacturer) takes a strategic minority position in the company.

Buyers
THEON INTERNATIONAL
Targets
Exosens
Sellers
HLD Europe
Location
Nouvelle-Aquitaine, France
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.